Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NSA2 pseudogene 5 (NSA2P5) is a human pseudogene related to the protein-coding NSA2 gene, which encodes a nucleolar protein involved in the biogenesis of the 60S ribosomal subunit and cell proliferation[2]. Pseudogenes such as NSA2P5 are defined as genomic DNA sequences similar to normal genes but typically nonfunctional due to mutations or truncations preventing the translation of a full-length, functional protein[2][3][4]. While some pseudogenes can have regulatory effects on their parental genes—such as acting as antisense RNAs, competing endogenous RNAs (ceRNAs), or sources of small interfering RNAs (siRNAs)—there is currently no evidence that NSA2P5 encodes a protein or acts as a therapeutic target[3][4][5]. It is not considered a receptor, enzyme, transporter, or any other standard drug target class. There is no information linking NSA2P5 to specific diseases, drug interactions, biomarker roles, or safety concerns. As such, it is not relevant for drug discovery or therapeutic intervention.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NSA2 pseudogene 5 (NSA2P5).